Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 A Goldhirsch, WC Wood, AS Coates, RD Gelber, B Thürlimann, HJ Senn Annals of oncology 22 (8), 1736-1747, 2011 | 4838 | 2011 |
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013 | 4326 | 2013 |
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of oncology 26 (8), 1533-1546, 2015 | 2240 | 2015 |
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer Breast International Group (BIG) 1-98 Collaborative Group New England Journal of Medicine 353 (26), 2747-2757, 2005 | 1966 | 2005 |
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn Annals of oncology 20 (8), 1319-1329, 2009 | 1956 | 2009 |
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 A Goldhirsch, JH Glick, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ... Annals of oncology 16 (10), 1569-1583, 2005 | 1582 | 2005 |
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ... Annals of oncology 18 (7), 1133-1144, 2007 | 1317 | 2007 |
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 1286 | 2015 |
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 1243 | 2017 |
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 AS Coates, A Keshaviah, B Thürlimann, H Mouridsen, L Mauriac, ... Journal of clinical oncology 25 (5), 486-492, 2007 | 1148 | 2007 |
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and … J Bonneterre, B Thurlimann, JFR Robertson, M Krzakowski, L Mauriac, ... Journal of clinical oncology 18 (22), 3748-3757, 2000 | 1128 | 2000 |
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thurlimann, HJ Senn Journal of clinical oncology 21 (17), 3357-3365, 2003 | 1011 | 2003 |
Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor positive advanced breast carcinoma: Results of two randomized trials designed for combined analysis J Bonneterre, A Buzdar, JMA Nabholtz, JFR Robertson, B Thürlimann, ... Cancer 92 (9), 2247-2258, 2001 | 732 | 2001 |
Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V M Colleoni, Z Sun, KN Price, P Karlsson, JF Forbes, B Thürlimann, ... Journal of clinical oncology 34 (9), 927, 2016 | 603 | 2016 |
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ... Annals of oncology 19 (3), 420-432, 2008 | 581 | 2008 |
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy … G Viale, MM Regan, E Maiorano, MG Mastropasqua, P Dell'Orto, ... Journal of Clinical Oncology 25 (25), 3846-3852, 2007 | 534 | 2007 |
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials BC Pestalozzi, D Zahrieh, E Mallon, BA Gusterson, KN Price, RD Gelber, ... Journal of clinical oncology 26 (18), 3006-3014, 2008 | 508 | 2008 |
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 HJ Burstein, G Curigliano, B Thürlimann, WP Weber, P Poortmans, ... Annals of oncology 32 (10), 1216-1235, 2021 | 495 | 2021 |
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical … MM Regan, P Neven, A Giobbie-Hurder, A Goldhirsch, B Ejlertsen, ... The lancet oncology 12 (12), 1101-1108, 2011 | 466 | 2011 |
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International … G Viale, A Giobbie-Hurder, MM Regan, AS Coates, MG Mastropasqua, ... Journal of clinical oncology 26 (34), 5569-5575, 2008 | 403 | 2008 |